235 related articles for article (PubMed ID: 24836404)
1. Cubosomes as targeted drug delivery systems - a biopharmaceutical approach.
Lakshmi NM; Yalavarthi PR; Vadlamudi HC; Thanniru J; Yaga G; K H
Curr Drug Discov Technol; 2014; 11(3):181-8. PubMed ID: 24836404
[TBL] [Abstract][Full Text] [Related]
2. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.
Han S; Shen JQ; Gan Y; Geng HM; Zhang XX; Zhu CL; Gan L
Acta Pharmacol Sin; 2010 Aug; 31(8):990-8. PubMed ID: 20686524
[TBL] [Abstract][Full Text] [Related]
3. Cubosomes: Versatile Nanosized Formulation for Efficient Delivery of Therapeutics.
Singhal K; Kaushik N; Kumar A
Curr Drug Deliv; 2022; 19(6):644-657. PubMed ID: 34238187
[TBL] [Abstract][Full Text] [Related]
4. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.
Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C
AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294
[TBL] [Abstract][Full Text] [Related]
5. Cubic-to-inverted micellar and the cubic-to-hexagonal-to-micellar transitions on phytantriol-based cubosomes induced by solvents.
Lotierzo MCG; Casadei BR; de Castro RD; Malheiros B; Barbosa LRS
Drug Deliv Transl Res; 2020 Dec; 10(6):1571-1583. PubMed ID: 32783155
[TBL] [Abstract][Full Text] [Related]
6. Cubosomes as an emerging platform for drug delivery: a review of the state of the art.
Abourehab MAS; Ansari MJ; Singh A; Hassan A; Abdelgawad MA; Shrivastav P; Abualsoud BM; Amaral LS; Pramanik S
J Mater Chem B; 2022 Apr; 10(15):2781-2819. PubMed ID: 35315858
[TBL] [Abstract][Full Text] [Related]
7. AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.
Flak DK; Adamski V; Nowaczyk G; Szutkowski K; Synowitz M; Jurga S; Held-Feindt J
Int J Nanomedicine; 2020; 15():7415-7431. PubMed ID: 33116479
[TBL] [Abstract][Full Text] [Related]
8. Cubosome: A Potential Liquid Crystalline Carrier System.
Sharma P; Dhawan S; Nanda S
Curr Pharm Des; 2020; 26(27):3300-3316. PubMed ID: 32552637
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM).
Rizwan SB; Dong YD; Boyd BJ; Rades T; Hook S
Micron; 2007; 38(5):478-85. PubMed ID: 17011783
[TBL] [Abstract][Full Text] [Related]
10. An Insight into Cubosomal Drug Delivery Approaches: An Explicative Review.
Mukherjee S; Dutta A; Ash D; Karati D
Pharm Nanotechnol; 2024 Jun; ():. PubMed ID: 38910488
[TBL] [Abstract][Full Text] [Related]
11. Vesicular approach of cubosomes, its components, preparation techniques, evaluation and their appraisal for targeting cancer cells.
Iqbal S; Zaman M; Waqar MA; Sarwar HS; Jamshaid M
J Liposome Res; 2024 Jun; 34(2):368-384. PubMed ID: 37873797
[TBL] [Abstract][Full Text] [Related]
12. Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability.
Yang Z; Tan Y; Chen M; Dian L; Shan Z; Peng X; Wu C
AAPS PharmSciTech; 2012 Dec; 13(4):1483-91. PubMed ID: 23090113
[TBL] [Abstract][Full Text] [Related]
13. A novel design for stable self-assembly cubosome precursor-microparticles enhancing dissolution of insoluble drugs.
Mei L; Xie Y; Jing H; Huang Y; Chen J; Ran H; Pan X; Wu C
Drug Dev Ind Pharm; 2017 Aug; 43(8):1239-1243. PubMed ID: 28276277
[TBL] [Abstract][Full Text] [Related]
14. Cubosomes: Innovative Nanostructures for Drug Delivery.
Duttagupta AS; Chaudhary HM; Jadhav KR; Kadam VJ
Curr Drug Deliv; 2016; 13(4):482-93. PubMed ID: 25707403
[TBL] [Abstract][Full Text] [Related]
15. The use of surfactants to enhance the solubility and stability of the water-insoluble anticancer drug SN38 into liquid crystalline phase nanoparticles.
Ranneh AH; Iwao Y; Noguchi S; Oka T; Itai S
Int J Pharm; 2016 Dec; 515(1-2):501-505. PubMed ID: 27793711
[TBL] [Abstract][Full Text] [Related]
16. Preparation, Characterization, and Antimicrobial Activity of Cubosome Encapsulated Metal Nanocrystals.
Meikle TG; Dyett BP; Strachan JB; White J; Drummond CJ; Conn CE
ACS Appl Mater Interfaces; 2020 Feb; 12(6):6944-6954. PubMed ID: 31917545
[TBL] [Abstract][Full Text] [Related]
17. Preparation of Cubosomes with Improved Colloidal and Structural Stability Using a Gemini Surfactant.
Nagao M; Ranneh AH; Iwao Y; Yamamoto K; Ikeda Y
Mol Pharm; 2023 Oct; 20(10):5066-5077. PubMed ID: 37726201
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
[TBL] [Abstract][Full Text] [Related]
19. An Update on the Recent Advances in Cubosome: A Novel Drug Delivery System.
Garg M; Goyal A; Kumari S
Curr Drug Metab; 2021; 22(6):441-450. PubMed ID: 33402079
[TBL] [Abstract][Full Text] [Related]
20. Microcontainers as an oral delivery system for spray dried cubosomes containing ovalbumin.
Nielsen LH; Rades T; Boyd B; Boisen A
Eur J Pharm Biopharm; 2017 Sep; 118():13-20. PubMed ID: 27993733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
